PatientGPS™ in Alzheimer’s Disease: Navigating the Use of Fluid Biomarker Testing for Early Disease Identification and Management
Webcast
1 AMA PRA Category 1 Credit™ ...Faculty
OVERVIEW
PatientGPS™ in Alzheimer’s Disease: Navigating the Use of Fluid Biomarker Testing for Early Disease Identification and Management is organized by Catamount Medical Education.
Released: December 16, 2024
Expires: December 16, 2025
Statement of Need/Program Overview:
The advent of disease-modifying therapies (DMTs) has significantly altered the treatment of Alzheimer’s disease (AD), making timely and accurate diagnosis essential for optimal management. Detecting AD pathology with imaging and fluid biomarkers is critical for identifying patients eligible for these newer therapies. As the fluid biomarker landscape evolves to include blood-based biomarkers alongside cerebrospinal fluid (CSF) testing, clinicians face challenges in integrating these tools into clinical practice. This case-based educational activity aims to equip health care professionals with the knowledge and confidence to appropriately and effectively apply fluid biomarker testing to facilitate early diagnosis and improve the management of patients with early symptomatic AD.
Educational Objectives:
After completing this activity, the participant should be better able to:
- Assess the advantages, limitations, and best practices for the use of CSF biomarkers in the early and accurate diagnosis of AD
- Discuss blood-based biomarkers for AD and their evolving role in research and clinical practice
- Incorporate into clinical practice evidence-based recommendations for the use of AD fluid biomarker testing to support early disease identification and guide the personalized management of early AD with DMTs
ACCREDITATION & CREDITS
Accredited Providers
This activity is jointly provided by Medical Education Resources and Catamount Medical Education.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Catamount Medical Education. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Physician Credit
Medical Education Resources designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources designates this enduring material for a maximum of 1.00 ANCC nursing contact hour.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.00 contact hour.
Physician Associate Credit
Medical Education Resources has been authorized by the American Academy of Physician Associate (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME Credit. Physician associates should only claim credit commensurate with the extent of their participation.
Maintenance of Certification (MOC) Credit
American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
TARGET AUDIENCE
PhysicianNursingPhysician AssistantNeurologistsGeriatricsNeuropsychologistsNurse PractitionersGeriatric PsychiatristsDementia SpecialistsSPECIALITIES
Neurology
Quick Links